SUBSCRIBE TO TMCnet
TMCnet - World's Largest Communications and Technology Community

TMC NEWS

TMCNET eNEWSLETTER SIGNUP

NeuroCog Trials Introduces NCT Pathway: Next Generation eCOA For Clinical Trials
[July 13, 2017]

NeuroCog Trials Introduces NCT Pathway: Next Generation eCOA For Clinical Trials


DURHAM, N.C., July 13, 2017 /PRNewswire/ -- NeuroCog Trials (NCT), a clinical technology and research services company dedicated to supporting global drug development, announces the general availability of its new flagship eCOA platform, NCT Pathway. Developed with input from seasoned clinical investigators, Pathway has the dynamic technical capabilities and user-driven design to meet the needs of virtually any clinical trial, from Alzheimer's disease and schizophrenia to oncology and cardiology. The platform is currently in use by large sponsors in several late stage clinical trials.

"I am thrilled to be presenting Pathway to the clinical trials community. We have dedicated ourselves to creating a tool that has a beautifully simple user interface, rigorous attention to scientific and regulatory detail, and a seamless back-end data transfer and storage system," said Co-Founder and CEO, Dr. Richard Keefe.

Other key benefits of NCT Pathway include: automated features and assisted scoring for improved protocol compliance, real-time data capture, central review portal, CDISC compliant storage and data transfer, and integrated security and regulatory compliance features. Recognized globally for expertise in clinical and cognitive measurement and data quality assurance, NeuroCog Trials implements rigorous testing and validation procedures to proactively anticipate challenges and ensure the highest level of performance across all its software solutions. NCT delivers innovative technology and science-driven data solutions with unrivaled dependability.

To learn more about NCT Pathway, please visit http:/www.neurocogtrials.com/products/pathway-ecoa/.

About NeuroCog Trials

NeuroCog Trials (NCT) is a cognition and clinical assessment services and technology company devoted exclusively to applying rigorous standards for key endpoints in multi-site clinical trials in many different indications. It has provided consulting, site screening, rater training and certification, translation, and data services for more than 100 clinical trials in over 25 countries. Founded in 2005, NCT is a privately held, certified woman-owned business, headquartered in Durham, North Carolina.



Contact

Jenna Piunti

Office

+1 919 433 2429

Switchboard

+1 919 401 4642

Email

Jenna.piunti@neurocogtrials.com

Website

www.neurocogtrials.com


View original content:http://www.prnewswire.com/news-releases/neurocog-trials-introduces-nct-pathway-next-generation-ecoa-for-clinical-trials-300488014.html

SOURCE NeuroCog Trials


[ Back To TMCnet.com's Homepage ]






Technology Marketing Corporation

35 Nutmeg Drive Suite 340, Trumbull, Connecticut 06611 USA
Ph: 800-243-6002, 203-852-6800
Fx: 203-866-3326

General comments: tmc@tmcnet.com.
Comments about this site: webmaster@tmcnet.com.

STAY CURRENT YOUR WAY

© 2017 Technology Marketing Corporation. All rights reserved | Privacy Policy